We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
-2.17%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$520M
AUM Growth
-$27.7M
Cap. Flow
-$13.6M
Cap. Flow %
-2.62%
Top 10 Hldgs %
32.77%
Holding
158
New
6
Increased
21
Reduced
108
Closed
10

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$4.7M
2
MMM icon
3M
MMM
+$3.69M
3
DRC
DRESSER-RAND GROUP INC
DRC
+$3.31M
4
DO
Diamond Offshore Drilling
DO
+$2.88M
5
INTC icon
Intel
INTC
+$2.5M

Sector Composition

Rank Sector Weight
1 Healthcare 25.16%
2 Industrials 19.16%
3 Technology 17.92%
4 Energy 8.19%
5 Utilities 7.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$599B
$30.8M 5.92%
288,937
-7,195
-2% -$746K
XOM icon
2
ExxonMobil
XOM
$615B
$20.8M 4%
221,251
-2,445
-1% -$244K
GLW icon
3
Corning
GLW
$132B
$20.3M 3.91%
1,051,839
-45,594
-4% -$951K
EMR icon
4
Emerson Electric
EMR
$76.5B
$17.6M 3.39%
281,448
+14,575
+5% +$946K
KO icon
5
Coca-Cola
KO
$353B
$16.3M 3.13%
381,996
-8,040
-2% -$332K
INTC icon
6
Intel
INTC
$488B
$15.3M 2.94%
438,477
-73,975
-14% -$2.5M
SLB icon
7
SLB Ltd
SLB
$69.4B
$12.6M 2.43%
124,035
-4,038
-3% -$440K
PFE icon
8
Pfizer
PFE
$141B
$12.6M 2.42%
448,189
+31,685
+8% +$889K
MRK icon
9
Merck
MRK
$307B
$12.2M 2.34%
215,028
-4,223
-2% -$237K
PLL
10
DELISTED
PALL CORP
PLL
$11.9M 2.29%
142,096
-317
-0.2% -$26K
BMY icon
11
Bristol-Myers Squibb
BMY
$123B
$11.5M 2.22%
225,252
-3,150
-1% -$157K
IBM icon
12
IBM
IBM
$200B
$10.8M 2.07%
59,413
-1,467
-2% -$267K
GSK icon
13
GSK
GSK
$100B
$10.2M 1.96%
177,356
+12,472
+8% +$765K
GXP
14
DELISTED
Great Plains Energy Incorporated
GXP
$9.1M 1.75%
376,475
-9,705
-3% -$246K
BCE icon
15
BCE
BCE
$20.2B
$8.44M 1.62%
197,483
+12,534
+7% +$560K
HON icon
16
Honeywell
HON
$71.7B
$8.28M 1.59%
98,943
-4,198
-4% -$357K
GVA icon
17
Granite Construction
GVA
$5.34B
$8.13M 1.56%
255,752
+6,410
+3% +$221K
CSCO icon
18
Cisco
CSCO
$436B
$7.84M 1.51%
311,335
-5,610
-2% -$141K
IDA icon
19
Idacorp
IDA
$8.15B
$7.12M 1.37%
132,745
-3,270
-2% -$180K
GE icon
20
GE Aerospace
GE
$354B
$6.8M 1.31%
55,397
+18,340
+49% +$2.29M
AZTA icon
21
Azenta
AZTA
$1.21B
$6.67M 1.28%
634,217
-17,071
-3% -$183K
AMGN icon
22
Amgen
AMGN
$197B
$6.64M 1.28%
47,248
-16,599
-26% -$2.17M
MSFT icon
23
Microsoft
MSFT
$2.99T
$6.47M 1.24%
139,555
-105,294
-43% -$4.7M
LNN icon
24
Lindsay Corp
LNN
$1.15B
$6.29M 1.21%
84,178
+6,430
+8% +$508K
NVS icon
25
Novartis
NVS
$285B
$5.94M 1.14%
70,374
-19,173
-21% -$1.55M

Similar funds

John G. Ullman & Associates's Q3 2014 Portfolio in Review

As of Q3 2014, John G. Ullman & Associates held 158 positions worth $520M, down 5.1% from $548M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

John G. Ullman & Associates's Q3 2014 filing shows 6 new, 21 increased, 108 reduced and 10 closed positions. Its largest new stake was CYTEC INDS INC: 74,750 shares worth $3.54M. The largest sale was Microsoft, an estimated $4.7M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 25% a quarter earlier, followed by Industrials and Technology.

  • John G. Ullman & Associates's largest Q3 2014 buy was CYTEC INDS INC: 74,750 shares worth $3.54M.
  • John G. Ullman & Associates added most to iShares MSCI Emerging Markets Min Vol Factor ETF in Q3 2014, an estimated $2.4M increase.
  • John G. Ullman & Associates's biggest Q3 2014 reduction was Microsoft, cutting an estimated $4.7M.
  • John G. Ullman & Associates fully exited Diamond Offshore Drilling in Q3 2014, selling an estimated $2.88M.
  • John G. Ullman & Associates's ten largest holdings make up 33% of its $520M portfolio in Q3 2014.
  • John G. Ullman & Associates opened 6 new positions and closed 10 in Q3 2014.
  • John G. Ullman & Associates's portfolio value fell 5.1% quarter-over-quarter to $520M.

Based on John G. Ullman & Associates's 13F filing for Q3 2014, filed 12 Nov 2014.